2. Academic Validation
  3. Reserpine improves Enterobacteriaceae resistance in chicken intestine via neuro-immunometabolic signaling and MEK1/2 activation

Reserpine improves Enterobacteriaceae resistance in chicken intestine via neuro-immunometabolic signaling and MEK1/2 activation

  • Commun Biol. 2021 Dec 3;4(1):1359. doi: 10.1038/s42003-021-02888-3.
Graham A J Redweik 1 2 3,  Michael H Kogut 4,  Ryan J Arsenault 5,  Mark Lyte 2 6,  Melha Mellata 7 8
Affiliations

Affiliations

  • 1 Department of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA.
  • 2 Interdepartmental Microbiology Graduate Program, Iowa State University, Ames, IA, USA.
  • 3 Molecular, Cellular & Developmental Biology, Colorado University-Boulder, Boulder, CO, USA.
  • 4 Southern Plains Agricultural Research Center, USDA-ARS, College Station, TX, USA.
  • 5 Department of Animal and Food Sciences, University of Delaware, Newark, DE, USA.
  • 6 Department of Veterinary Microbiology and Preventive Medicine, Iowa State University, Ames, IA, USA.
  • 7 Department of Food Science and Human Nutrition, Iowa State University, Ames, IA, USA. [email protected].
  • 8 Interdepartmental Microbiology Graduate Program, Iowa State University, Ames, IA, USA. [email protected].
PMID: 34862463 DOI: 10.1038/s42003-021-02888-3
Abstract

Salmonella enterica persist in the chicken gut by suppressing inflammatory responses via expansion of intestinal regulatory T cells (Tregs). In humans, T cell activation is controlled by neurochemical signaling in Tregs; however, whether similar neuroimmunological signaling occurs in chickens is currently unknown. In this study, we explore the role of the neuroimmunological axis in intestinal Salmonella resistance using the drug reserpine, which disrupts intracellular storage of catecholamines like norepinephrine. Following reserpine treatment, norepinephrine release was increased in both ceca explant media and Tregs. Similarly, Salmonella killing was greater in reserpine-treated explants, and oral reserpine treatment reduced the level of intestinal Salmonella Typhimurium and other Enterobacteriaceae in vivo. These antimicrobial responses were linked to an increase in antimicrobial peptide and IL-2 gene expression as well as a decrease in CTLA-4 gene expression. Globally, reserpine treatment led to phosphorylative changes in epidermal growth factor receptor (EGFR), mammalian target of rapamycin (mTOR), and the mitogen-associated protein kinase 2(MEK2). Exogenous norepinephrine treatment alone increased Salmonella resistance, and reserpine-induced antimicrobial responses were blocked using beta-adrenergic receptor inhibitors, suggesting norepinephrine signaling is crucial in this mechanism. Furthermore, EGF treatment reversed reserpine-induced antimicrobial responses, whereas mTOR inhibition increased antimicrobial activities, confirming the roles of metabolic signaling in these responses. Finally, MEK1/2 inhibition suppressed reserpine, norepinephrine, and mTOR-induced antimicrobial responses. Overall, this study demonstrates a central role for MEK1/2 activity in reserpine induced neuro-immunometabolic signaling and subsequent antimicrobial responses in the chicken intestine, providing a means of reducing Bacterial colonization in chickens to improve food safety.

Figures
Products